Delusional infestation (DI) is defined as a fixed and false belief of a skin infestation by a pathogen. Although primarily a psychiatric condition, dermatologists see the majority of these challenging patients (1). Herein, we present 3 patients with symptoms mimicking those of DI, all caused by medical treatments increasing dopaminergic activity.
of her symptoms. One month later, she discontinued ropinirole and started pregabalin 75 mg twice a day for treatment of her restless leg syndrome. After one week, she had complete resolution of her delusional infestation. Case 3. A 62-year-old man with a history of attention deficit hyperactivity disorder (ADHD) presented with complaints of scabies in his scalp for the past 8 months. He described scabies "burrowing into his scalp, and moving" and seeing scabies' eggs "raining" from his scalp. He had been treated with multiple courses of ivermectin and permethrin cream with no resolution, and had started self-treatment by applying malathion to his scalp.
His past medical history was significant for a 30-year history of ADHD, treated with dextroamphetamine/amphetamine 120 mg daily (3-fold greater than the recommended maximum dosage of 40 mg for treatment of ADHD). Additionally, he was taking armodafinil, a dopamine reuptake inhibitor, 250 mg daily for "sleepiness during the day".
On physical examination, he had normal affect and pleasant mood. His scalp showed erythema, with pink eczematous patches extending onto the frontal forehead as well as on the tops of the pinnae. There was no evidence of nits or lice noted. Over his chest, upper back, arms, and ankles he had excoriations and pink scaly patches.
Based on his history and physical exam, he was diagnosed with DI, secondary to armodafinil and dextroamphetamine/ amphetamine, and a contact dermatitis. He was advised to stop applying permethrin, malathion, and hair dyes to his scalp, and was given topical steroids that resolved his contact dermatitis. Most importantly, his psychiatrist was consulted and armodafinil was discontinued and dextroamphetamine/amphetamine was weaned to 60 mg daily.
At follow-up one month later, the patient's delusional state had totally resolved and his excoriations and rashes improved significantly.
DISCUSSION
Pathophysiology of DI is unknown, although a compelling theory suggests dopamine as a major player in its manifestation. Huber et. al. (3) proposed a mechanism of DI involving dysfunction of the dopamine transporter (DAT), which acts to regulate the level of dopamine in the brain by removing it from the extracellular space. If DAT is malfunctioning, the level of dopamine at the synaptic cleft increases. DAT is located at the presynaptic nerve terminal and has a dense distribution in the striatum, specifically the putamen (3, 4) .
Interestingly, this fronto-striato-thalamo-parietal network has been associated with DI and overlaps with the striato-thalamo-orbitofrontal circuit that is enhanced in chronic itch (5). Therefore, an increased level of dopamine activating this circuit may explain why these patients feel sensations of itch and desires to scratch.
Treatment-induced Delusions of Infestation Associated with Increased Brain Dopamine Levels
Emilie FOWLER 1, 2 , Andrea MADERAL 1 and Gil YOSIPOVITCH 1, 2 In all 3 cases, treatments that increased dopamine levels in the brain caused symptoms of delusional infestation. Case 1 was a Parkinson's patient undergoing DBS. Parkinson's disease has been previously reported to cause secondary DI due to the use of dopaminergic medications (6, 7) . However, to our knowledge, no cases have been reported of DBS causing symptoms of DI. The mechanism of DBS is poorly understood, but some evidence shows that electrical stimulation of the subthalamic nucleus, which has neuronal projections to the substantia nigra, leads to activation of surviving nigrostriatal neurons, which leads to increased dopamine release in the striatum (8) . Perhaps after each DBS device reprogramming, the patient experienced a brief hyperdopaminergic state, leading to these delusions. Unlike other cases of DI, our patient would regain insight immediately following each episode.
In case 2, ropinirole, a dopamine agonist, is another medication altering the effect of dopamine at the synaptic cleft. It directly stimulates the dopamine receptors at the postsynaptic nerve terminal and has been reported in cases of DI (6) .
Case 3 was taking a dose of dextroamphetamine/ amphetamine that was 3-fold the FDA recommended maximum dose. Dextroamphetamine/amphetamine reverses the action of DAT, causing dopamine to flow into the extracellular space (9) . Armodafinil, the R-isomer of modafinil, also affects dopamine by blocking DAT, leading to an increase of dopamine in the brain (10) . Although, to our knowledge, there are no reported cases of armodafanil or modafinil causing DI, their binding to DAT overlaps with the binding site of cocaine, which has been implicated in cases mimicking DI (10) .
In summary, these 3 cases illustrate that drugs and treatments increasing dopamine can cause a somatic response resembling delusional infestation. Dermatologists should be aware of these associations.
